Salesforce Inc (NYSE:CRM) shares moved higher Wednesday after the company secured a major win with Novartis selecting its Agentforce Life Sciences platform for global customer engagement, while BTIG initiated coverage with a Buy rating and a $335 price target.What Happened: BTIG analyst Allan Ver... Read more
Benzinga - Dec 17
Salesforce Inc. (NYSE:CRM) delivered a rebuttal to fears of stalled AI adoption in its third-quarter earnings report Wednesday, presenting data that directly contradicts recent channel checks suggesting customers were stuck in “pilot purgatory.”CRM stock is gaining positive traction. Get the insi... Read more
Benzinga - Dec 04
'Mad Money' host Jim Cramer breaks down this week's market action in Salesforce, the company's revenue growth outlook, and more. Read more
Cnbc - Oct 18
